1101 Protein crystallization promotes type 2 immunity and is reversible by antibody treatment.
https://science.sciencemag.org/content/364/6442/eaaw4295
1100 Fusion proteins in cancers with low mutational burden represent functional neoantigens that elicit T cell activation and mediate responses to immunotherapy.
https://www.nature.com/articles/s41591-019-0434-2
1099 Rational design of anti-GITR-based combination immunotherapy.
https://www.nature.com/articles/s41591-019-0420-8
1098 Distinct phenotype of CD4+ T cells driving celiac disease identified in multiple autoimmune conditions.
https://www.nature.com/articles/s41591-019-0403-9
1097 B cells engineered to express pathogen-specific antibodies protect against infection.
https://immunology.sciencemag.org/content/4/35/eaax0644
1096 Protect, modify, deprotect (PMD): A strategy for creating vaccines to elicit antibodies targeting a specific epitope.
https://www.pnas.org/content/116/20/9947
1095 Influenza A virus mimetic nanoparticles trigger selective cell uptake.
https://www.pnas.org/content/116/20/9831
1094 T cell response, tumor immunity, and autoimmunity are attenuated by PD-1 in mice lacking cis-PD-L1/CD80 interaction.
https://science.sciencemag.org/content/364/6440/558
1093 Human natural killer cells mediate adaptive immunity to viral antigens.
https://immunology.sciencemag.org/content/4/35/eaat8116
1092 Yeast-secreted, dried and food-admixed monomeric IgA prevents gastrointestinal infection in a piglet model.
https://www.nature.com/articles/s41587-019-0070-x
|
